Dysmorphism due to warfarin
ICD-10 Q86.2 is a billable code used to indicate a diagnosis of dysmorphism due to warfarin.
Dysmorphism due to warfarin refers to congenital malformations that arise as a result of maternal exposure to warfarin during pregnancy. Warfarin is an anticoagulant medication that can cross the placenta and interfere with fetal development, leading to a range of dysmorphic features. Common manifestations include nasal hypoplasia, limb deformities, and central nervous system anomalies. The severity and type of malformations can vary significantly based on the timing of exposure during gestation. The condition is part of a broader category of congenital malformations and can be associated with other congenital anomalies such as skin, breast, spleen, and adrenal malformations. Accurate coding requires a thorough understanding of the patient's history, including maternal medication use, and a detailed clinical assessment of the infant's physical features. Documentation should include specific dysmorphic features observed, gestational age at exposure, and any associated congenital conditions to ensure comprehensive coding and appropriate management.
Pediatric documentation should include a comprehensive physical examination, detailed descriptions of dysmorphic features, and any associated congenital anomalies.
Common scenarios include newborns presenting with characteristic dysmorphic features, requiring evaluation for potential congenital anomalies.
Consideration should be given to the timing of maternal warfarin exposure and its impact on fetal development.
Genetic documentation should include family history, maternal medication use, and results from genetic testing if applicable.
Genetic counseling scenarios may involve discussing risks associated with warfarin exposure and potential genetic implications.
Geneticists should be aware of the teratogenic effects of warfarin and the need for thorough evaluation of associated genetic conditions.
Used for follow-up visits in patients with congenital dysmorphism due to warfarin.
Documentation should include a review of systems, physical examination findings, and assessment of growth and development.
Pediatricians should ensure that all aspects of the patient's history and physical exam are documented.
Common dysmorphic features include nasal hypoplasia, limb deformities, and central nervous system anomalies. The specific features can vary based on the timing of maternal exposure to warfarin during pregnancy.
